PTC Therapeutics | PTCT - EPS Earnings Per Share


PTC Therapeutics reported $-1.67 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 -0.43 10.04 Apr/23
FY2025Q4 Dec/2025 -1.67 -0.47 -0.85 Feb/19
FY2025Q3 Sep/2025 0.20 -1.02 -1.39 Nov/04
FY2025Q2 Jun/2025 -0.83 -1.07 -1.29 Aug/07
FY2025Q1 Mar/2025 10.04 -1.35 -1.20 May/06




Eps Change Date
Acadia Pharmaceuticals USD 1.6 1.18 Dec/2025
Alnylam Pharmaceuticals USD 1.25 1.65 Dec/2025
Amgen USD 5.29 0.35 Dec/2025
BioCryst Pharmaceuticals USD 1.17 1.1 Dec/2025
Biogen USD 1.99 2.82 Dec/2025
BioMarin Pharmaceutical USD 0.46 0.34 Dec/2025
Cytokinetics USD -1.5 1.05 Dec/2025
Daiichi Sankyo JPY 46.79 22.27 Dec/2025
Enanta Pharmaceuticals USD -1.05 0.31 Dec/2024
Esperion Therapeutics USD 0.26 0.42 Dec/2025
Gilead Sciences USD 1.86 0.61 Dec/2025
Incyte USD 1.8 0.46 Dec/2025
Ionis Pharmaceuticals USD -1.41 0.61 Dec/2025
Ironwood Pharmaceuticals USD -0.01 0.25 Dec/2025
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
Novartis USD 1.54 0.5 Dec/2025
Pfizer USD 0.66 0.21 Dec/2025
PTC Therapeutics USD -1.67 1.87 Dec/2025
Puma Biotechnology USD 0.41 0.5 Sep/2024
Roche Holding CHF 8.37 2.95 Dec/2025
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sarepta Therapeutics USD -3.58 3.45 Dec/2025
TG Therapeutics USD 0.14 2.29 Dec/2025
Ultragenyx Pharmaceutical USD -1.29 0.52 Dec/2025
Vertex Pharmaceuticals USD 5.03 0.23 Dec/2025
Xencor USD -0.09 0.01 Dec/2025